GENPHARMASEC LIMITED (GENPHARMA.BO)
INR 3.42
(0.89%)
INR 3.42
(0.89%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 304.05 Million | 255.15 Million | 273.2 Million | 213.07 Million | 165.01 Million | 3.75 Million |
| Cost of Revenue | 250.38 Million | 239.53 Million | 268.33 Million | 194 Million | 153.7 Million | 172.54 Thousand |
| Gross Profit | 53.66 Million | 15.61 Million | 4.86 Million | 19.07 Million | 11.3 Million | 3.57 Million |
| Operating Expenses | 53.63 Million | 13.24 Million | 10.22 Million | 7.25 Million | 4.82 Million | 4.45 Million |
| Selling, General and Administrative Expenses | 33.36 Million | 13.24 Million | 10.2 Million | 7.25 Million | 4.81 Million | 4.44 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 20.27 Million | - | -20 Thousand | -2500.00 | -12.5 Thousand | -12.5 Thousand |
| Cost and Expenses | 304.01 Million | 252.78 Million | 278.56 Million | 201.25 Million | 158.52 Million | 4.62 Million |
| Operating Income | 38 Thousand | 2.37 Million | -5.35 Million | 11.81 Million | 6.48 Million | -874.35 Thousand |
| Interest Expense | 4.09 Million | 560 Thousand | - | - | - | - |
| Income Tax Expense | 4.19 Million | -8.43 Million | -2.33 Million | 2.52 Million | 1.96 Million | 565.92 Thousand |
| Earnings before Tax | 2.5 Million | 2.81 Million | -4.43 Million | 15.09 Million | 12.05 Million | 2.87 Million |
| Net Income | -1.25 Million | 11.24 Million | -2.09 Million | 12.57 Million | 10.09 Million | 2.3 Million |
| Earnings Per Share Basic | -0.00 | 0.02 | -0.00 | 0.03 | 0.03 | 0.01 |
| Earnings Per Share Diluted | -0.00 | 0.02 | -0.00 | 0.03 | 0.03 | 0.01 |
| Weighted Average Shares Outstanding | 307.2 Million | 461.08 Million | 461.08 Million | 451.77 Million | 361.15 Million | 361.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 307.2 Million | 461.08 Million | 461.08 Million | 451.77 Million | 361.15 Million | 361.15 Million |
| Gross Margin | 0.18 | 0.06 | 0.02 | 0.09 | 0.07 | 0.95 |
| EBIT Margin | 0.00 | 0.01 | -0.02 | 0.06 | 0.04 | -0.23 |
| Profit Margin | -0.00 | 0.04 | -0.01 | 0.06 | 0.06 | 0.62 |
| EBITDA | 459 Thousand | 2.57 Million | -4.28 Million | 15.22 Million | 12.1 Million | 2.87 Million |
| Earnings Before Tax Margin | 0.00 | 0.01 | -0.02 | 0.06 | 0.04 | -0.23 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 51.95 Million | 304.05 Million | 101.98 Million | 63.84 Million | 78.58 Million | 59.64 Million |
| Cost of Revenue | 44.86 Million | 250.38 Million | 83.82 Million | 52.25 Million | 68.05 Million | 46.32 Million |
| Gross Profit | 7.08 Million | 53.66 Million | 18.15 Million | 11.59 Million | 10.53 Million | 13.31 Million |
| Operating Expenses | 6.86 Million | 53.63 Million | 18.59 Million | 11.47 Million | 10.95 Million | 13.16 Million |
| Selling, General and Administrative Expenses | 6.86 Million | - | 18.59 Million | 11.47 Million | 10.95 Million | 13.16 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -20.27 Million | - | -1.04 Million | - | - |
| Cost and Expenses | 51.72 Million | 304.01 Million | 102.42 Million | 63.72 Million | 79 Million | 59.48 Million |
| Operating Income | 221 Thousand | 38 Thousand | -442 Thousand | 118 Thousand | -419 Thousand | 156 Thousand |
| Interest Expense | 1.01 Million | 4.09 Million | 1.56 Million | 1.24 Million | 650 Thousand | 629 Thousand |
| Income Tax Expense | 2 Million | 4.19 Million | 3.78 Million | -336 Thousand | 375 Thousand | 384 Thousand |
| Earnings before Tax | 4.87 Million | 2.5 Million | 1.1 Million | 298 Thousand | 455 Thousand | 646 Thousand |
| Net Income | 2.86 Million | -1.25 Million | -2.23 Million | 634 Thousand | 79 Thousand | 261 Thousand |
| Earnings Per Share Basic | 0.01 | - | -0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share Diluted | 0.01 | - | -0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Shares Outstanding | 533.71 Million | 307.2 Million | 533.71 Million | 461.08 Million | 461.08 Million | 461.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 533.71 Million | 307.2 Million | 533.71 Million | 461.08 Million | 461.08 Million | 461.08 Million |
| Gross Margin | 0.14 | 0.18 | 0.18 | 0.18 | 0.13 | 0.22 |
| EBIT Margin | 0.03 | - | -0.00 | 0.00 | -0.01 | 0.00 |
| Profit Margin | 0.06 | -0.00 | -0.02 | 0.01 | 0.00 | 0.00 |
| EBITDA | 1.78 Million | - | -145 Thousand | 165 Thousand | -411 Thousand | 226 Thousand |
| Earnings Before Tax Margin | 0.00 | 0.00 | -0.00 | 0.00 | -0.01 | 0.00 |
GATE
SPOI
SLSDF
HBIE
032350
DIABIO